New patent expiration for Merck Sharp drug JUVISYNC

00:06 EST 2 Feb 2019 | BiotechBlog

Annual Drug Patent Expirations for JUVISYNC Juvisync is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are seven patents protecting this drug and three…
The post New patent expiration for Merck Sharp drug JUVISYNC appeared first...

The post New patent expiration for Merck Sharp drug JUVISYNC appeared first on Biotechblog.

Original Article: New patent expiration for Merck Sharp drug JUVISYNC

More From BioPortfolio on "New patent expiration for Merck Sharp drug JUVISYNC"